First nasal spray for treating adult COVID-19 patients launc

Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.

Related Keywords

Mumbai , Maharashtra , India , Robert Crockart , Monika Tandon , Srikanth Krishnamurthy , Utah State University United States , Glenmark Pharmaceuticals Ltd , Nitric Oxide Nasal Spray , Drugs Controller General , Oxide Nasal Spray , Nitric Oxide Nasal , Chief Commercial Officer Robert Crockart , Clinical Development , Glenmark Pharmaceuticals , Principal Investigators , First , Nasal , Spray , Or , Reating , Adult , Covid 19 , Patients , Aunched , N , News , Ews India ,